Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 3, 2019
Previous Article Next Article

Applications of nanoparticles in biomedical imaging

Author affiliations

Abstract

An urgent need for early detection and diagnosis of diseases continuously pushes the advancements of imaging modalities and contrast agents. Current challenges remain for fast and detailed imaging of tissue microstructures and lesion characterization that could be achieved via development of nontoxic contrast agents with longer circulation time. Nanoparticle technology offers this possibility. Here, we review nanoparticle-based contrast agents employed in most common biomedical imaging modalities, including fluorescence imaging, MRI, CT, US, PET and SPECT, addressing their structure related features, advantages and limitations. Furthermore, their applications in each imaging modality are also reviewed using commonly studied examples. Future research will investigate multifunctional nanoplatforms to address safety, efficacy and theranostic capabilities. Nanoparticles as imaging contrast agents have promise to greatly benefit clinical practice.

Graphical abstract: Applications of nanoparticles in biomedical imaging

Back to tab navigation

Publication details

The article was received on 25 Sep 2018, accepted on 20 Dec 2018 and first published on 24 Dec 2018


Article type: Review Article
DOI: 10.1039/C8NR07769J
Citation: Nanoscale, 2019,11, 799-819

  •   Request permissions

    Applications of nanoparticles in biomedical imaging

    X. Han, K. Xu, O. Taratula and K. Farsad, Nanoscale, 2019, 11, 799
    DOI: 10.1039/C8NR07769J

Search articles by author

Spotlight

Advertisements